Cargando…

Disease burden of hepatitis C in the Austrian state of Tyrol – Epidemiological data and model analysis to achieve elimination by 2030

BACKGROUND: In 2016, the World Health Organization (WHO) and 69th World Health Assembly approved the first global health sector strategy (GHSS) on viral hepatitis with the goal to eliminate hepatitis C virus (HCV) infections worldwide. The aim is a 90% reduction of new infections and 65% reduction o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schaefer, Benedikt, Viveiros, André, Al-Zoairy, Ramona, Blach, Sarah, Brandon, Samantha, Razavi, Homie, Dorn, Livia, Finkenstedt, Armin, Effenberger, Maria, Graziadei, Ivo, Sarcletti, Mario, Tilg, Herbert, Zoller, Heinz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042769/ https://www.ncbi.nlm.nih.gov/pubmed/30001427 http://dx.doi.org/10.1371/journal.pone.0200750

Ejemplares similares

Transmission of oral microbiota to the biliary tract during endoscopic retrograde cholangiography
por: Effenberger, Maria, et al.
Publicado: (2023)

Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
por: Müllhaupt, Beat, et al.
Publicado: (2018)

Indications for liver transplantation in adults: Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX)
por: Graziadei, Ivo, et al.
Publicado: (2016)

Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
por: Schaefer, Benedikt, et al.
Publicado: (2016)

Heterozygosity for the alpha‐1‐antitrypsin Z allele in cirrhosis is associated with more advanced disease
por: Schaefer, Benedikt, et al.
Publicado: (2018)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Transferrin as a predictor of survival in cirrhosis
por: Viveiros, André, et al.
Publicado: (2018)

Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)
por: Reiberger, Thomas, et al.
Publicado: (2017)

Prescription of oral antidiabetic drugs in Tyrol – Data from the Tyrol diabetes registry 2012–2015
por: Lunger, Lukas, et al.
Publicado: (2016)

Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease
por: Viveiros, André, et al.
Publicado: (2020)

Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case report
por: Al-Zoairy, R., et al.
Publicado: (2020)

Beyond the COVID-19 crisis: A research note on post-pandemic scenarios for South Tyrol 2030+
por: Habicher, Daria, et al.
Publicado: (2022)

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach
por: Busschots, Dana, et al.
Publicado: (2022)

Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19
por: Blach, Sarah, et al.
Publicado: (2021)

Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside—a systematic review and meta‐analysis
por: Schaefer, Benedikt, et al.
Publicado: (2020)

Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress
por: Blach, Sarah, et al.
Publicado: (2023)

Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach
por: Benzaken, Adele Schwartz, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease burden: Australia, 2019–2030
por: Adams, Leon A, et al.
Publicado: (2020)

Impact of COVID-19 on global HCV elimination efforts
por: Blach, Sarah, et al.
Publicado: (2021)

Neurodegeneration in Hepatic and Neurologic Wilson’s Disease
por: Viveiros, André, et al.
Publicado: (2021)

Hepatitis elimination by 2030: Progress and challenges
por: Waheed, Yasir, et al.
Publicado: (2018)

Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-Study
por: Kaltseis, Katharina, et al.
Publicado: (2022)

Tyrol Petitions for a Veterinary School
Publicado: (1896)

Countdown to 2030: eliminating hepatitis B disease, China
por: Liu, Jue, et al.
Publicado: (2019)

Towards the elimination of FGM by 2030: A statistical assessment
por: Weny, Kathrin, et al.
Publicado: (2020)

Towards the elimination of viral hepatitis in Thailand by the year 2030
por: Posuwan, Nawarat, et al.
Publicado: (2020)

Hepatitis C elimination by 2030 in Malaysia: an achievable goal?
por: Mohamed, Rosmawati, et al.
Publicado: (2019)

Eliminating morbidity caused by neglected tropical diseases by 2030
por: Gyorkos, Theresa, et al.
Publicado: (2023)

2030 – Countdown to malaria elimination in India and southeast Asia
por: The Lancet Regional Health – Southeast Asia
Publicado: (2022)

Prevalence and differences of ideal cardiovascular health in urban and rural adolescents in the Region of Tyrol: results from the EVA Tyrol study
por: Hochmayr, C., et al.
Publicado: (2021)

The impact of immigration on hepatitis B burden in the United States: a modelling study
por: Razavi-Shearer, Devin, et al.
Publicado: (2023)

The Environmental Spread of Aspergillus terreus in Tyrol, Austria
por: Dietl, Anna-Maria, et al.
Publicado: (2021)

Rabies Elimination by 2030: What Challenges Does Iran Face?
por: EBRAHIMZADEH LEYLABADLO, Hamed, et al.
Publicado: (2020)

Elimination of hepatitis C in Australia by 2030: a decade and counting
por: Dore, Gregory J
Publicado: (2021)

Modelling NAFLD disease burden in four Asian regions—2019‐2030
por: Estes, Chris, et al.
Publicado: (2020)

Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals
por: Gountas, Ilias, et al.
Publicado: (2019)

Molecular Screening of Blood Donors for Babesia in Tyrol, Austria
por: Bloch, Evan M., et al.
Publicado: (2023)

Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example
por: Altraif, Ibrahim
Publicado: (2018)

Global investment targets for malaria control and elimination between 2016 and 2030
por: Patouillard, Edith, et al.
Publicado: (2017)

Is Singapore on track to eliminate tuberculosis by 2030? A policy case study
por: Tam, Greta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1o92d6b03n6nhr27l22cjm77pc